Telix Pharmaceuticals (ASX:TLX) announces leadership changes

Company News

by Lauren Evans

Darren Smith will take over Doug Cubbin as chief financial officer of Telix Pharmaceuticals (ASX:TLX).

Smith joined Telix in February this year as deputy CFO, and prior to this, he was global CFO and company secretary at Sirtex Medical. Cubbin will step down on July 31, having joined the company in 2017 before its IPO.

Telix’s chief operating officer Gabriel Liberatore will also step down on July 31.

Telix advised that a new CEO for the American region has been identified, after chief executive officer Christian Behrenbruch assumed the additional role of interim CEO, Telix Americas in February.

Shares are trading 2.2 per cent lower at $4.56.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.